ROBERT T. SCHOOLEY, M.D.; ROBERT W. CAREY, M.D.; GEORGE MILLER, M.D.; WERNER HENLE, M.D.; ROBIN EASTMAN, B.S.; EUGENE J. MARK, M.D.; KENNETH KENYON, M.D.; EDWIN O. WHEELER, M.D.; ROBERT H. RUBIN, M.D.
Two patients developed fever, interstitial pneumonitis, and pancytopenia associated with extremely high titers of antibody to replicative antigens of the Epstein-Barr virus. In contrast to most patients seropositive for Epstein-Barr virus, neither patient had an antibody response to the Epstein-Barr nuclear antigen K polypeptide. In addition, virus isolated from one patient had a deletion of the B95-8 type in the EcoRI C region of the genome. An etiologic relation between Epstein-Barr virus replication and the clinical manifestations of this syndrome is further shown by the response of each patient to acyclovir therapy. These patients have a new Epstein-Barr-virus-associated syndrome and provide additional evidence that acyclovir may play a role in therapy for selected patients with Epstein-Barr virus infection.
SCHOOLEY RT, CAREY RW, MILLER G, et al. Chronic Epstein-Barr Virus Infection Associated with Fever and Interstitial Pneumonitis: Clinical and Serologic Features and Response to Antiviral Chemotherapy. Ann Intern Med. 1986;104:636–643. doi: https://doi.org/10.7326/0003-4819-104-5-636
Download citation file:
Published: Ann Intern Med. 1986;104(5):636-643.
Infectious Disease, Interstitial Lung Disease, Pulmonary/Critical Care.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use